Treatment outcome of adolescents with acute lymphoblastic leukemia

Annals of Hematology

Volumn 81, Issue 11, 2002, Pages 641-645

  Irken, G ^a   Oren H ^a   Gullen H ^a   Duman, M ^a   Ucar C ^a   Atabay, B ^a   Yilmaz, S ^a   Uysal, K ^a   Cevik N ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Adolescent; Children; Lymphoblastic leukemia; Survival

Indexed keywords

METHOTREXATE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; FEMALE; GENDER; HUMAN; IMMUNOPHENOTYPING; LABORATORY TEST; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE; PREDNISONE; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036941156     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0551-7     Document Type: Article

References (33)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for classification of the acute leukemias. French-American-British (FAB) cooperative group. Br J Haematol 33:451-458
2. Camitta BM, Pullen J, Murphy S (1997) Biology and treatment of acute lymphoblastic leukemia in children. Semin Oncol 24:83-91
3. Chessels JM, Bailey C, Richards SM (1995) Intensification of treatment and survival in all children with lymphoblastic leukemia: result of UK Medical Research Council Trial UKALL X. Lancet 345:143-148
4. Conter V, Arico M, Valsecchi MG, Basso G, Biondi A, Madon E, Mandelli F, Paolucci G, Pession A, Rizzari C, Rondelli R, Zanesco L, Masera G (2000) Long term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982-1995. Leukemia 14:2196-2204
5. Crist W, Boyett J, Pullen J, van Eys J, Vietti T (1986) Clinical and biological features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group study. Blood 67:135-140
6. Crist W, Pullen J, Boyett J, Falletta J, van Eys J, Borowitz M, Jackson J, Dowell B, Russell C, Quddus F, Ragab A, Vietti T (1988) Acute lymphoid leukemia in adolescents: clinical and biologic features predict a poor prognosis - a Pediatric Oncology Group study. J Clin Oncol 6:34-43
7. Eden OB, Harrison G, Richards S, Lilleyman JS, Bailey CC, Chessells JM, Hann IM, Hill FG, Gibson BE (2000) Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Leukemia 14:2307-2320
8. Frankel LS, Ochs J, Shuster JJ, Dubowy R, Bowman WP, Hockenberry-Eaton M, Borowitz M, Carroll AJ, Steuber CP, Pullen DJ (1997) Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493). J Pediatr Hematol Oncol 19:35-42
9. Gaynon PS, Tirgg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD, Bleyer WA (2000) Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 14:2223-2233
10. Gurney JG, Severson RK, Davis S, Robison LL (1995) Incidence of cancer in children in the United States. Cancer 75:2186-2191
11. Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Makipernaa A, Nygaard R, Saarinen-Pihkala UM (2000) Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high dose methotrexate in the reduction of CNS irradiation. Nordic society of Pediatric Hematology and Oncology (NOPHO). Leukemia 14:2267-2275
12. Harms DO, Janka-Schaub GE, on behalf of the COALL Study Group (2000) Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia 14:2234-2239
13. Kamps WA, Veerman AJ, van Wering ER, van Weerden JF, Slater R, van der Does-van den Berg A (2000) Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991. Leukemia 14:2240-2246
14. Liesner R, Goldstone AH (1997) Treatment of childhood and adulthood acute lymphoblastic leukemia. J Intern Med 242:S29-S36
15. Maloney KW, Shuster JJ, Murphy S, Pullen J, Camitta BA (2000) Long term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia 14:2276-2285
16. Nachman J, Sather HN, Gaynon Ps, Lukens JN, Wolff L, Trigg ME (1997) Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group. J Clin Oncol 15:2222-2230
17. Pui CH (1997) Acute lymphoblastic leukemia. Pediatr Oncol 44:831-846
18. Pui CH, Boyett JM, Rivera GK, Hancock ML, Sandlund JT, Ribeiro RC, Rubnitz JE, Behm FG, Raimondi SC, Gajjar A, Razzouk B, Campana D, Kun LE, Relling MV, Evans WE (2000) Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia 14:2286-2294
19. Pui CH, Crist WM (1994) Biology and treatment of acute lymphoblastic leukemia. J Pediatr 124:491-503
20. Pui CH, Raimondi SC, Dodge RK, Rivera GK, Fuchs LA, Abromowitch M, Look AT, Furman WL, Crist WM, Williams DL (1989) Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (>50 chromosomes) acute lymphoblastic leukemia. Blood 73:1963-1967
21. Riehm H, Schrappe M, Dördelmann M, for the German ALL-BFM Study Group (1995) Multicentric co-operative study for acute lymphoblastic leukemia, ALL-BFM 95. ALL-BFM 95 Protocol Booklet, Hannover, pp 1-89
22. Rivera GK, Pui CH, Santana VM, Hancock ML, Mahmoud H, Sandlund JT, Ribeiro RC, Furman W, Marina N, Crist WM (1993) Progress in the treatment of adolescents with acute lymphoblastic leukemia. Cancer 71:3400-3405
23. Santana VM, Dodge RK, Crist WM, Rivera GK, Look AT, Behm FG, Raimondi SC, Pui CH (1990) Presenting features and treatment outcome of adolescents with acute lymphoblastic leukemia. Leukemia 4:87-90
24. Sather HN (1986) Age at diagnosis in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 14:166-172
25. Schrappe M, Reiter A, Ludwing WD, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, Kornhuber B, Ritter J, Welte K, Gadner H, Riehm H (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood 95:3310-3322
26. Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G, Gadner H, Odenwald E, Riehm H (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia 14:2205-2222
27. Shuster JJ, Faletta JM, Pullen DJ, Crist WM, Humphrey GB, Dowell BL, Wharam MD, Borowitz M (1990) Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 75:166-173
28. Silverman LB, Declerck L, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Lipton JM, Cohen HJ, Sallan SE (2000) Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995). Leukemia 14:2247-2256
29. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R (1996) Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14:18-24
30. Smith SD, Rosen D, Trueworthy R, Lowman JT (1979) A reliable method for evaluating drug compliance in children with cancer. Cancer 43:169-173
31. Tsuchida M, Ikuta K, Hanada R, Saito T, Isoyama K, Sugita K, Toyoda Y, Manabe A, Koike K, Kinoshita A, Maeda M, Ishimoto K, Sato T, Okimato Y, Kaneko T, Kajiwara M, Sotomatsu M, Hayashi Y, Yabe H, Hosoya R, Hoshi Y, Ohira M, Bessho F, Tsunematsu Y, Tsukimoto I, Nakazawa S (2000) Long-term follow-up childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981-1985. Leukemia 14:2295-2306
32. van der Does-van den Berg A, Bartram CR, Basso G, Benoit YC, Biondi A, Debatin KM, Haas OA, Harbott J, Kamps WA, Koller U (1992) Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the BFM Family Cooperative Group. Med Pediatr Oncol 20:497-503
33. Vilmer E, Suciu S, Ferster A, Bertrand Y, Cave H, Thyss A, Benoit Y, Dastugue N, Fournier M, Souillet G, Manel AM, Robert A, Nelken B, Millot F, Lutz P, Rialland X, Mechinaud F, Boutard P, Behar C, Chantraine JM, Plouvier E, Laureys G, Brock P, Uyttebroeck A, Margueritte G, Plantaz D, Norton L, Francotte N, Gyselinck J, Waterkeyn C, Solbu G, Philippe N, Otten J (2000) Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Leukemia 14:2257-2266